Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04906525 · ClinicalTrials.gov registry record · NA
Resistance Training Effects on Gut Microbiome and Cardiometabolic Outcomes
A NA study, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT04906525: Completed NA study, sponsored by University of Missouri-Columbia.
NCT04906525 is a NA study that has completed, run by University of Missouri-Columbia. The registered enrollment target is 34 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04906525, a NA study, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
The overall objective of this study is to investigate the effects of resistance training on the gut microbiome and cardiometabolic outcomes in adults with overweight and obesity.
Primary Outcome
16s rRNA sequencing
Interventions
- BEHAVIORAL Resistance training
- OTHER Conventional physical activity guidelines
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2021-05-19 |
| Est. Completion | 2022-09-30 |
| Phase | NA |
What the finished NCT04906525 record still lists
NCT04906525 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Resistance training is the first listed.
NCT04906525 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04906525 about?
NCT04906525 is a clinical study titled "Resistance Training Effects on Gut Microbiome and Cardiometabolic Outcomes". The overall objective of this study is to investigate the effects of resistance training on the gut microbiome and cardiometabolic outcomes in adults with overweight and obesity.
What is the current status of trial NCT04906525?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2021-05-19. Estimated completion is 2022-09-30.
What interventions are being tested in trial NCT04906525?
The interventions under investigation include: Resistance training (BEHAVIORAL), Conventional physical activity guidelines (OTHER).
Who is sponsoring clinical trial NCT04906525?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04906525's enrollment target sits among peer trials
34 1570th of 2000 higher than 427 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI